Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.5000
+0.0500 (11.11%)
May 21, 2026, 3:37 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 34.1 million as of May 21, 2026. Its market cap has decreased by -29.98% in one year.
Market Cap
34.10M
Enterprise Value
34.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 34.10M, a decrease of -61.72%. That is a compound annual growth rate of -17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 34.10M | -17.43% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 60.75M |
| Sernova Biotherapeutics | 58.44M |
| Quantum BioPharma | 54.10M |
| Medicenna Therapeutics | 45.05M |
| MedMira | 42.10M |
| Lobe Sciences | 41.19M |
| Devonian Health Group | 31.01M |
| Microbix Biosystems | 31.00M |